Table: begin end state 1 44 cytoplasmic 45 67 transmembrane 68 79 non-cytoplasmic 80 100 transmembrane 101 133 cytoplasmic 134 153 transmembrane 154 161 non-cytoplasmic 162 184 transmembrane 185 190 cytoplasmic 191 210 transmembrane 211 224 non-cytoplasmic 225 248 transmembrane 249 256 cytoplasmic 257 277 transmembrane 278 282 non-cytoplasmic 283 301 transmembrane 302 320 cytoplasmic 321 341 transmembrane 342 371 non-cytoplasmic 372 395 transmembrane 396 406 cytoplasmic 407 434 transmembrane 435 456 non-cytoplasmic 457 474 transmembrane 475 505 cytoplasmic
Input: >WP_012115873.1 NCBI__GCF_000017645.1:WP_012115873.1 MAHPPVADLKPEVLPKGDLPAPGLPGAPTLPPPTPHQGAASVIGSAFTDAIVSGLLTGLL LLPLVGFRATESGSGPLGLTYRFGLVAVFAGIVAVLRLVLNLTVWRRGRKVKVSAGPSAF TTLAQKAAPALRPAFFSFAIAYPFLAILLAGGLSPSRYWVDLGIYVLTYVMLGWGLNIVV GLAGLLDLGYVAFYAVGAYTFALLSTSVPVNDFFAGHLGEGFWTAWSFWLCLPVSGLLAA FWGVILGFPVLRLRGDYLAIVTLAFGEIIRLVLINWVSLTNGGAGISSIPPISFFGVPFN ATDEGFAAKYGLDFDSMHRIIFLYFVILGLAALTALVTIRLRQMPVGRAWEALREDEIAC RSLGINTTLTKLTAFATGAMFGGFAGAFFAVRVRFVSPESFTFMESAVILAIVVLGGMGS QMGVAGAAILLIGGMEMLRNLSFLKADFLFGPDFDPSLYRMLIFGFAMVAVMVWRPRGLV SSRLPTIFLKERKAVSSALVKEGHG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server